These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2555215)

  • 1. Testing cell activation and cytokine release in serum-supplemented cultures: methodical note concerning polymyxin B.
    Flegel WA; Rich IN; Schilling ML; Northoff H
    Eur J Haematol; 1989 Oct; 43(4):359-60. PubMed ID: 2555215
    [No Abstract]   [Full Text] [Related]  

  • 2. The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production.
    Duff GW; Atkins E
    J Immunol Methods; 1982 Aug; 52(3):333-40. PubMed ID: 6290568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyxin B inactivation of lipopolysaccharide in vaccines of Gram-negative bacteria.
    Cooperstock M; Riegle L
    Infect Immun; 1981 Jul; 33(1):315-8. PubMed ID: 6266967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of human MLR by very low concentrations of lipopolysaccharide and blocking of this enhancement by polymyxin B.
    Spear GT; Teodorescu M
    J Immunol Methods; 1984 Oct; 73(2):321-7. PubMed ID: 6092477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyxin-B inhibition of LPS-induced interleukin-1 secretion by human monocytes is dependent upon the LPS origin.
    Cavaillon JM; Haeffner-Cavaillon N
    Mol Immunol; 1986 Sep; 23(9):965-9. PubMed ID: 3023974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of human interleukin-1 production by polymyxin B.
    Damais C; Jupin C; Parant M; Chedid L
    J Immunol Methods; 1987 Jul; 101(1):51-6. PubMed ID: 3039003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of endotoxin from culture media by a polymyxin B sepharose column. The activity of contaminating endotoxin in culture media measured by the interleukin 1 inducing effect on human monocyte cultures and by the Limulus test.
    Mølvig J; Baek L
    Scand J Immunol; 1987 Dec; 26(6):611-9. PubMed ID: 2827297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymyxin B prevents lipopolysaccharide-induced release of tumor necrosis factor-alpha from alveolar macrophages.
    Stokes DC; Shenep JL; Fishman M; Hildner WK; Bysani GK; Rufus K
    J Infect Dis; 1989 Jul; 160(1):52-7. PubMed ID: 2543712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of polysaccharide components in polymyxin B treated cells of Serratia marcescens.
    Weber DA; Nadakavukaren MJ; Tsang JC
    J Antibiot (Tokyo); 1978 Jul; 31(7):732-5. PubMed ID: 211111
    [No Abstract]   [Full Text] [Related]  

  • 10. Polymyxin B inhibits biphasic calcium phosphate degradation induced by lipopolysaccharide-activated human monocytes/macrophages.
    Kimakhe S; Heymann D; Guicheux J; Pilet P; Giumelli B; Daculsi G
    J Biomed Mater Res; 1998 May; 40(2):336-40. PubMed ID: 9549629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemical structure of the lipopolysaccharide of A Rc-type mutant of Proteus mirabilis lacking 4-amino-4-deoxy-L arabinose and its susceptibility towards polymyxin B.
    Radziejewska-Lebrecht J; Bhat UR; Brade H; Kaca W; Mayer H
    Adv Exp Med Biol; 1990; 256():121-6. PubMed ID: 2158212
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitogenic response of mouse spleen cells and gelation of limulus lysate by lipopolysaccharide of Yersinia pestis and evidence for neutralization of lipopolysaccharide by polymyxin B.
    Butler T; Möller G
    Infect Immun; 1977 Nov; 18(2):400-4. PubMed ID: 200563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of polymyxin B on endotoxemia in severe liver diseases (author's transl)].
    Iwasaki M; Kumashiro R; Wada T; Maeyama T; Nagata E; Kawaguchi M; Abe H; Tanikawa K
    Nihon Shokakibyo Gakkai Zasshi; 1982 Feb; 79(2):241-8. PubMed ID: 6285045
    [No Abstract]   [Full Text] [Related]  

  • 14. Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B.
    Cohen J; McConnell JS
    Eur J Clin Microbiol; 1986 Feb; 5(1):13-7. PubMed ID: 3009177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyocin-resistant lipopolysaccharide mutans of Neisseria gonorrhoeae: alterations in sensitivity to normal human serum and polymyxin B.
    Guymon LF; Esser M; Shafer WM
    Infect Immun; 1982 May; 36(2):541-7. PubMed ID: 6282751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies on the antipyretic action of polymyxin B in pyrogen-induced fever.
    van Miert AS; van Duin CT
    Arzneimittelforschung; 1978; 28(12):2246-51. PubMed ID: 227419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation between endotoxin and non-endotoxin pyrogens in human albumin solutions using an ex vivo whole blood culture assay.
    Pool EJ; Johaar G; James S; Petersen I; Bouic P
    J Immunoassay; 1999; 20(1-2):79-89. PubMed ID: 10225516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified proteins as possible signals in the acute phase response.
    Koj A; Guzdek A
    Ann N Y Acad Sci; 1995 Jul; 762():108-18; discussion 118-9. PubMed ID: 7668522
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose-dependent reduction of lipopolysaccharide pyrogenicity by polymyxin B.
    Warner SJ; Mitchell D; Savage N; McClain E
    Biochem Pharmacol; 1985 Nov; 34(22):3995-8. PubMed ID: 2998395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell activating properties of polymyxin B.
    Smith CI; Hammarström L
    Scand J Immunol; 1978; 7(1):67-72. PubMed ID: 204983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.